Table 2. Univariate and multivariate analyses on the disease-free survival of 102 cases of ovarian cancer.
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
HR | P > |z| | 95% CI | HR | P > |z| | 95% CI | |
SPAG5 expression | ||||||
High versus Low | 5.06 | 0.001* | 2.705–9.458 | 3.57 | 0.001* | 1.782–7.158 |
Age (years) | ||||||
≥60 versus <60 | 1.26 | 0.417 | 0.719–2.216 | |||
Tumour size (cm) | ||||||
>5 versus ≤5 | 2.23 | 0.064 | 0.955–5.191 | |||
Histological type | ||||||
Serous versus mucinous versus Endometroid versus clear cell |
1.22 | 0.250 | 0.870–1.704 | |||
Pathological grade | ||||||
Grade 1 and 2 versus Grade 3 | 0.63 | 0.031* | 0.417–0.958 | 0.98 | 0.936 | 0.645–1.497 |
Lymph node metastasis | ||||||
Positive versus negative | 3.77 | 0.001* | 2.225–6.379 | 1.04 | 0.909 | 0.550–1.958 |
Distant metastasis | ||||||
Positive versus negative | 4.38 | 0.001* | 2.507–7.666 | 4.42 | 0.070 | 0.886–22.099 |
TNM stage | ||||||
Stage I versus Stage II versus Stage III versus Stage Stage IV |
0.26 | 0.001* | 0.167–0.392 | 0.11 | 0.002* | 0.025–0.447 |
P < 0.05